‘Act together’ to meet changes to in-vitro diagnostic regulations

Young scientist working with samples in a lab

Commissioned by Innovate UK, ISO Life Sciences Ltd was asked to look at the state of readiness of the UK in-vitro diagnostic sector ahead of new EU regulations.

The regulations are due to come into force on 26 May 2022.

Issues, challenges and needs

Innovate UK’s intent is to raise awareness of the issues, challenges and needs of the UK in-vitro diagnostics (IVD) sector and to engage critical stakeholders to help formulate action plans.

The report notes:

In response to the needs placed on the UK IVD sector, government and regulators, has emerged the unprecedented demonstration by all parties to operate in such a way as to get things done.

What has emerged is closer cooperation across business silos, changes to working practices between businesses, accelerated business actions for results.

Key recommendation

The report’s key recommendation is:

In relation to IVD regulations transitioning, the UK IVD sector, policy makers and regulators, notified bodies and government agencies need to similarly ‘act together’.

Dr Michael Kipping, Innovate UK’s Innovation Lead, Biomedical Catalyst, said:

The report highlights that throughout the COVID-19 pandemic the in-vitro diagnostic sector has achieved much by acting together.

By taking the same approach the sector can meet the challenge of regulatory change.

Top image: Credit: Marco VDM/GettyImages

NOTE Council web content is being transitioned to this website – let us know if you have feedback or would like to help us test new developments.